Question follow-through · 557
Pharmacy: Higher Education
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of giving pharmacy students studying for MPharm degrees in England access to the NHS Learning Support Fund.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 13 May 2026
- Target answer date
- 18 May 2026
- Answer
- 18 May 2026 · 5 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
13 May 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of giving pharmacy students studying for MPharm degrees in England access to the NHS Learning Support Fund.
18 May 2026
Target answer date
Date supplied by the official written-questions record.
18 May 2026
Answer published
For the 2025 to 2026 academic year, the Government extended the Learning Support Fund (LSF) scheme’s Travel and Dual Accommodation Expenses provision to pre-registration pharmacy and healthcare science students to ensure they are reimbursed for the additi...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.